Operational Obstetrics & Gynecology
Norplant
|
2014 Editor's Note: Norplant is no longer available. A similar product is now available in several forms, Nexplanon, Implanon and Implanon NXT.
Information about these other products can be found here.
Norplant consists of six soft, flexible Silastic tubes, each containing levonorgestrel (LNG, the same progestational agent found in LoOvral), and implanted just below the skin of the inner, upper arm. The tubes are 34 mm long and 2.4 mm in diameter, and initially release about 85 mcg of LNG each day. In time, the daily release of LNG falls, ultimately stabilizing at about 30 mcg per day. If left in place, the tubes continue to effectively prevent pregnancy for at least 5 years.
It is believed to exert its' contraceptive effect by some or all of the following:
- Inhibiting ovulation
- Changing cervical mucous
- Changing the lining of the uterus
- Altering fallopian tube function
- Other, as yet unclassified mechanisms
When removed, fertility returns promptly.
During the first year of use, the failure rate is 0.2%, comparable to the failure rate of BCPs. During the next 5 years, the failure rate rises slowly to about 1% by the 5th year.
- Undiagnosed vaginal bleeding
- Known or suspected pregnancy
- Known or suspected breast cancer
- Active thrombophlebitis or thromboembolism
- History of idiopathic intracranial hypertension
- Benign or malignant liver tumors or other acute liver disease
- Known hypersensitivity to LNG or Silastic
About half of all women using Norplant will experience abnormal bleeding patterns, consisting of spotting, prolonged bleeding, unpredictable onset of flow and amenorrhea, primarily in the first year of use. While overall, the number of days of some bleeding in these women usually increases, the total amount of blood loss usually decreases, and anemia is not a problem. This side effect, abnormal bleeding, is generally tolerated and no treatment is necessary. For the woman who is quite distressed, or in whom the bleeding is clinically significant, control with BCPs is usually effective, but may alter the effectiveness of the method and theoretically could lead to an increased risk of thrombophlebitis or other hormone-related side effect. Removal of the implants may occasionally be necessary.
Weight Gain or Loss/Nausea/Depression
These have all been reported in association with this drug, but it is unknown whether they occur more frequently among women using the implants or not using the implants. If the symptoms are mild, toleration will usually bring relief in time. If symptoms are severe, removal of the implants may be necessary.
Infection at the implant site is an uncommon complication (0.7%), but is treated by removal of the implants, bacterial cultures and antibiotics.
The implants are inserted in the inner, upper arm (non-dominant side), 8-10 cm above the elbow crease, in a fan-like pattern, just beneath the dermis.
When in place, they are typically invisible, but may be seen in extremely thin patients.
In women with darker skin tones, a hyperpigmentation (even darker area) may develop over the implants, outlining their position, but this coloration is temporary and resolves after removal of the implants. They can be felt, but will not move or migrate away from the insertion site.
After giving a small amount of local anesthetic, 2 mm incision in the skin is made and a trocar introduced. Through the trocar, the Silastic tubes are inserted in a fan-like fashion. The incision to closed with a steri-strip.
Local anesthetic is injected to allow a 3-5 mm skin incision at the base of the "fan." 3 ml of anesthetic in injected beneath the implants. Push one implant toward the incision with your fingers and grasp it with a hemostat. Before it can be removed, you will need to open the fibrous capsule which will have developed around the implant. Open the capsule with a scalpel or another hemostat. Then grasp the implant and pull it straight out through the incision. Continue in the same way with the other implants until all 6 are removed.
Sometimes, there will have been some migration of the implants, making removal of all of them difficult. Under these circumstances, if reasonable efforts to retrieve all of them are not successful, it may be better to stop, wait 4-6 weeks for healing and resolution of any inflammation, and then try again.
New implants may be inserted at the time of the removal of the old ones, either in the same or in the opposite direction
Contents - Introduction - Medical Support of Women in Field Environments - The Prisoner of War Experience - Routine Care - Pap Smears - Human Papilloma Virus - Contraception - Birth Control Pills - Vulvar Disease - Vaginal Discharge - Abnormal Bleeding - Menstrual Problems - Abdominal Pain - Urination Problems - Menopause - Breast Problems - Sexual Assault - Normal Pregnancy - Abnormal Pregnancy - Normal Labor and Delivery - Problems During Labor and Delivery - Care of the Newborn
|
Bureau of Medicine
and Surgery |
Operational
Obstetrics & Gynecology - 2nd Edition |
This web version of Operational Obstetrics & Gynecology is provided by The Brookside Associates. It contains original contents from the official US Navy NAVMEDPUB 6300-2C, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense. All material in this version is unclassified.
This formatting C. 2006
Brookside Associates, LLC.
All rights reserved
